Downregulated gene products include putative tumor suppressor genes (SCUBE2), factors previously reported as lost in aggressive bladder cancer (FOXA1, GATA3, UPK3A), and metabolizing enzymes with polymorphisms affecting cancer risk (UGT1A10, UGT1A7). This evidence concerns the gene SCUBE2 and urinary bladder cancer.